Dyadic International shares are trading higher after the company announced continued progress across multiple global health collaborations validating its proprietary C1 protein production platform potential.
Dyadic International shares are trading higher after the company announced continued progress across multiple global health collaborations validating its proprietary C1 protein production platform potential.
benzinga_article
Dyadic International shares are trading higher after the company announced continued progress across multiple global health collaborations validating its proprietary C1 protein production platform potential.
